Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 235-239, 2013.
Article
in English
| WPRIM
| ID: wpr-78904
ABSTRACT
Several chemotherapeutic agents are known to develop pulmonary toxicities in cancer patients, although the frequency of incidence varies. Cyclophosphamide is a commonly encountered agent that is toxic to the lung. Additionally, granulocyte colony-stimulating factor (G-CSF) being used for the recovery from neutropenia can exacerbate lung injury. However, most of the patients reported previously that the drug-induced interstitial pneumonitis were developed after three to four cycles of chemotherapy. Hereby, we report a case of peripheral T cell lymphoma which rapidly developed a fatal interstitial pneumonitis after the first cycle of combined chemotherapy with cyclophosphamide, adriamycin, vincristine, prednisolone, and etoposide and the patient had also treated with G-CSF during neutropenic period.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Vincristine
/
Prednisolone
/
Doxorubicin
/
Incidence
/
Granulocyte Colony-Stimulating Factor
/
Lymphoma, T-Cell, Peripheral
/
Lung Diseases, Interstitial
/
Cyclophosphamide
/
Drug Therapy, Combination
/
Etoposide
Type of study:
Incidence study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS